Potential viral pathogenic mechanism for new variant inflammatory bowel disease.

Department of Pathology, Coombe Women's Hospital, Dublin 8, Ireland.
Molecular Pathology 05/2002; 55(2):84-90.
Source: PubMed

ABSTRACT A new form of inflammatory bowel disease (ileocolonic lymphonodular hyperplasia) has been described in a cohort of children with developmental disorder. This study investigates the presence of persistent measles virus in the intestinal tissue of these patients (new variant inflammatory bowel disease) and a series of controls by molecular analysis.
Formalin fixed, paraffin wax embedded and fresh frozen biopsies from the terminal ileum were examined from affected children and histological normal controls. The measles virus Fusion (F) and Haemagglutinin (H) genes were detected by TaqMan reverse transcription polymerase chain reaction (RT-PCR) and the Nucleocapsid (N) gene by RT in situ PCR. Localisation of the mRNA signal was performed using a specific follicular dendritic cell antibody.
Seventy five of 91 patients with a histologically confirmed diagnosis of ileal lymphonodular hyperplasia and enterocolitis were positive for measles virus in their intestinal tissue compared with five of 70 control patients. Measles virus was identified within the follicular dendritic cells and some lymphocytes in foci of reactive follicular hyperplasia. The copy number of measles virus ranged from one to 300,00 copies/ng total RNA.
The data confirm an association between the presence of measles virus and gut pathology in children with developmental disorder.

Download full-text


Available from: Orla Sheils, Jun 21, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper aims to discuss various aspects of the use of reference genes in qPCR technique used in the thousands of present studies. Most frequently, these are housekeeping genes and they must meet several criteria so that they can lay claim to the name. Lots of papers report that in different conditions, for different organisms and even tissues the basic assumption-the constant level of the expression is not maintained for many genes that seem to be perfect candidates. Moreover, their transcription can not be affected by experimental factors. Sounds simple and clear but a great number of designed protocols and lack of consistency among them brings confusion on how to perform experiment properly. Since during selection of the most stable normalizing gene we can not use any reference gene, different ways and algorithms for their selection were developed. Such methods, including examples of best normalizing genes in some specific cases and possible mistakes are presented based on available sources. Numerous examples of reference genes applications, which are usually in too few numbers in relevant articles not allowing to make a solid fundament for a reader, will be shown along with instructive compilations to make an evidence for presented statements and an arrangement of future qPCR experiments. To include all the pitfalls and problems associated with the normalization methods there is no way not to begin from sample preparation and its storage going through candidate gene selection, primer design and statistical analysis. This is important because numerous short reviews available cover the topic only in lesser extent at the same time giving the reader false conviction of complete topic recognition.
    Journal of applied genetics 09/2013; DOI:10.1007/s13353-013-0173-x · 1.90 Impact Factor
  • Source
    Clinical and Developmental Immunology 07/2004; 11(2):165-74. DOI:10.1080/10446670410001722096 · 2.93 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: One of the biggest challenges to professionals involved in immunisation delivery in recent years has been the controversy surrounding the safety of the measles, mumps and rubella (MMR) vaccine. This article explores the history of the vaccine, the controversy and its impact on uptake rates. In discussion potential winners and losers are considered with the conclusion being that there are very few winners among the affected healthcare professionals, children, parents, the NHS and UK government .
    British Journal of Infection Control 02/2007; 8(1):18-22. DOI:10.1177/14690446070080010901